ResMed Inc. (RMD) Financials

RMD Assets vs Liabilities
DateAssetsLiabilities
Sept. 30, 2026 8.2 billion 2.3 billion
June 30, 2026 9.0 billion 2.4 billion
March 31, 2026 8.8 billion 2.3 billion
Dec. 31, 2025 8.5 billion 2.2 billion

RMD Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2026 373.7 million 29.5 million
June 30, 2026 1.6 billion 104.3 million
March 31, 2026 520.5 million 26.8 million
Dec. 31, 2025 305.2 million 28.9 million

RMD Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
Sept. 30, 2026 418.4 million
June 30, 2026 1.5 billion
March 31, 2026 398.7 million
Dec. 31, 2025 392.6 million

RMD Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2026 1.0 billion 249.6 million 201.0 million
June 30, 2026 1.5 billion 399.4 million 166.6 million
March 31, 2026 1.7 billion 404.2 million 179.1 million
Dec. 31, 2025 1.4 billion 558.1 million 154.1 million

RMD Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2026 143.4 million
June 30, 2026 145.0 million
March 31, 2026 147.0 million
Dec. 31, 2025 147.0 million

RMD Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2026 48.7 million 102.9 million 314.7 million -
June 30, 2026 156.3 million 105.7 million 296.3 million -
March 31, 2026 33.7 million 94.3 million 279.8 million -
Dec. 31, 2025 34.6 million 91.0 million 278.4 million -

RMD Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2026 1.4 billion 544.2 million
June 30, 2026 1.5 billion 602.4 million
March 31, 2026 1.4 billion 540.4 million
Dec. 31, 2025 1.4 billion 538.1 million

RMD Revenue by Segment
Graph available only for paid members. Upgrade to see it.

RMD

List: Contenders

Price: $236.13

52 week price:
179.75
284.87

Dividend Yield: 1.08%

5-year range yield:
0.61%
1.40%

Forward Dividend Yield: 1.10%

Payout Ratio: 30.59%

Payout Ratio Range:
-72.31%
523.30%

Dividend Per Share: 2.64 USD

Earnings Per Share: 10.98 USD

P/E Ratio: 21.90

Exchange: NYQ

Sector: Healthcare

Industry: Medical Instruments & Supplies

Country: United States

Volume: 1.2 million

Ebitda: 178.5 million

Market Capitalization: 33.8 billion

Average Dividend Frequency: 4

Years Paying Dividends: 15

DGR3: 8.83%

DGR5: 7.07%

DGR10: 6.78%

Links: